Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -93.01M | -48.41M | -33.28M | -837.67M | -81.89M |
| Total Depreciation and Amortization | 48.28M | 56.09M | 56.00M | 68.09M | 69.63M |
| Total Amortization of Deferred Charges | 41.89M | 35.58M | 35.82M | 30.76M | 30.88M |
| Total Other Non-Cash Items | 59.25M | 31.90M | 37.20M | 837.09M | 42.21M |
| Change in Net Operating Assets | -40.49M | 10.74M | 14.44M | -9.59M | -51.91M |
| Cash from Operations | 15.92M | 85.90M | 110.18M | 88.68M | 8.92M |
| Capital Expenditure | -2.73M | -6.13M | -1.60M | -1.91M | -1.15M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -64.61M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.93M | -23.51M | -29.55M | -25.84M | -34.36M |
| Cash from Investing | -123.27M | -29.64M | -31.15M | -27.75M | -35.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 769.00K | 2.06M | 957.00K | 3.83M | 1.65M |
| Repurchase of Common Stock | -- | -- | -176.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -83.00K | -23.00K | 104.00K |
| Cash from Financing | 769.00K | 2.06M | 698.00K | 3.81M | 1.75M |
| Foreign Exchange rate Adjustments | 1.59M | -3.86M | 1.76M | -292.00K | -899.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.00M | 54.46M | 81.48M | 64.45M | -25.74M |